Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Hôpital régional de Sudbury Regional Hospital CELLULITIS CARE MAP INCLUSION CRITERIA: Acute Mild/Moderate Cellulitis (inflammation & redness) Fever (temperature greater than/equal to 38.0°C) Mild/Moderate Pain associated with Cellulitis EXCLUSION CRITERIA: Chronic Cellulitis Suspected necrotizing fasciitis, osteomyelitis, or septic arthritis Infected diabetic or decubitis ulcers Postoperative wound infections Orbital Cellulitis TESTS (Medical Directive # EDOS01) Bloodwork: CBCD, Electrolytes, Urea, Creatinine, Random Glucose, Calcium Blood Cultures X 2 if temperature greater than/equal to 38.0°C Wound Care swab from infected site Baseline & daily INR level if patient on Warfarin (Coumadin) and receiving fluoroquinolones antibiotics ASSESSMENT Vital Signs (temperature, pulse, blood pressure, respiration, oxygen saturation) Postural Vitals – Lying down for full 5 minutes and Standing (High Fowler’s if unable to stand) for full 2 minutes Mental Status including any changes from baseline Hydration Status (mucus membranes) C/O pain, type and location Affected area of Cellulitis (mark & measure area, drainage) TREATMENT OPTIONS (Medical Directive # EDOS04) Saline lock Intervenous therapy MEDICATIONS*********CHECK ALLERGIES & MEDICATION COMPATIBILITY****** (Medical Directive # EDOS03) FIRST LINE Cephalexin Ceftriaxone SECOND LINE Cloxacillin Clindamycin ORAL 500mg QID X 7 days (max) or until physician r/a PARENTERAL --1gm daily X 7-10 days 500mg QID X 7 days (max) or until physician r/a 300 – 450 mg QID X 7 days (max) or until physician r/a ----- MEDICATIONS*********CHECK ALLERGIES & MEDICATION COMPATIBILITY****** (Medical Directive # EDOS03) Acetaminophen (Tylenol) 325-975mg po (650mg pr) q4hrs prn Hôpital régional de Sudbury Regional Hospital ONGOING MEASURES Review wound care C&S results & adjust medications accordingly Monitor and mark the border of the affected area daily. Notify LTC if affected area is increasing Nutrition – Regular diet or as ordered (encourage fluids unless contraindicated) Activity as tolerated – if non-ambulatory patient ensure repositioning q2hrs Physiotherapy Occupational Therapy REFERENCES Dong, S., Kelly, K., Oland, R., Holroyd, B., Rowe, B. (2001). ED Management of Cellulitis: A review of Five Urban Centers. American Journal of Emergency Medicine, 19(7), 535-540). Murray, H., Stiell, I., & Wells, G. (2005). Treatment failure in emergency department patients with cellulitis. Canadian Journal of Emergency Medicine, 7(4), 228-234. Rosser, W., Pennie, R., Pilla, N., and the Anti-infective Review Panel. (2005). Anti-infective guidelines for community-acquired infections. Toronto: MUMS Guideline Clearinghouse. Seaton, R., Bell, E., Gourlay, Y., & Semple, L. (2005). Nurse-led management of uncomplicated cellulitis in the community: evaluation of a protocol incorporating intravenous ceftriaxone. Journal of Antimicrobial Chemotherapy, 55, 764-767.